ABVC
ABVC BioPharma (ABVC)
$52
About ABVC BioPharma (ABVC)
ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.
Details
Daily high
$0.53
Daily low
$0.49
Price at open
$0.51
52 Week High
$2.45
52 Week Low
$0.41
Market cap
6.8M
Dividend yield
0.00%
Volume
100,301
Avg. volume
389,974
P/E ratio
-.58
ABVC BioPharma News
Details
Daily high
$0.53
Daily low
$0.49
Price at open
$0.51
52 Week High
$2.45
52 Week Low
$0.41
Market cap
6.8M
Dividend yield
0.00%
Volume
100,301
Avg. volume
389,974
P/E ratio
-.58